It's well established that STAT3 is a critical mediator of tumorigenesis, tumor progression, and suppression of anti‐tumor therapy in GBM.[2] Here, we identify the SH2 containing adaptor protein, SHF, which acts as a tumor suppressor in GBM via a novel mechanism involving STAT3 regulation. Here, STAT3 is linked to glioblastoma.